Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
2009 1
2010 2
2012 2
2013 2
2014 1
2017 1
2018 4
2019 7
2021 2
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
An MDS Evidence-Based Review on Treatments for Huntington's Disease.
Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C. Ferreira JJ, et al. Mov Disord. 2022 Jan;37(1):25-35. doi: 10.1002/mds.28855. Epub 2021 Nov 29. Mov Disord. 2022. PMID: 34842303 Review.
BACKGROUND: Huntington's disease (HD) is a rare neurodegenerative disorder with protean clinical manifestations. ...There was no eligible evidence to support the use of specific treatments for depression, psychosis, irritability, apathy, or suicidality
BACKGROUND: Huntington's disease (HD) is a rare neurodegenerative disorder with protean clinical manifestations. ...There was …
Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
Schultz JL, Killoran A, Nopoulos PC, Chabal CC, Moser DJ, Kamholz JA. Schultz JL, et al. Neurology. 2018 Jul 17;91(3):e202-e207. doi: 10.1212/WNL.0000000000005817. Epub 2018 Jun 20. Neurology. 2018. PMID: 29925548
OBJECTIVE: To determine whether tetrabenazine (TBZ) use is associated with an increased incidence of depression and/or suicidal ideation. ...Among only participants with a history of depression, those using TBZ had a lower incidence of depres
OBJECTIVE: To determine whether tetrabenazine (TBZ) use is associated with an increased incidence of depression and/or suic
Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.
Solmi M, Pigato G, Kane JM, Correll CU. Solmi M, et al. Drug Des Devel Ther. 2018 May 14;12:1215-1238. doi: 10.2147/DDDT.S133205. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29795977 Free PMC article. Review.
MATERIALS AND METHODS: We conducted a literature search in PubMed, Cochrane Database, and ClinicalTrials.gov, screening for systematic reviews, meta-analyses or double-blind, randomized, placebo-controlled trials (DBRPCTs) reporting efficacy or safety data of VMAT-2 inhibitors ( …
MATERIALS AND METHODS: We conducted a literature search in PubMed, Cochrane Database, and ClinicalTrials.gov, screening for systematic revie …
Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia.
Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Woods SW, Bega D, LeDoux MS, Shprecher DR, Anderson KE. Fernandez HH, et al. J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1317-1323. doi: 10.1136/jnnp-2018-319918. Epub 2019 Jul 10. J Neurol Neurosurg Psychiatry. 2019. PMID: 31296586 Free PMC article. Clinical Trial.
Safety measures included incidence of adverse events (AEs) and scales used to monitor parkinsonism, akathisia/restlessness, anxiety, depression, suicidality and somnolence/sedation. Efficacy endpoints included the change in Abnormal Involuntary Movement Scale (AIMS) …
Safety measures included incidence of adverse events (AEs) and scales used to monitor parkinsonism, akathisia/restlessness, anxiety, depr
Tetrabenazine and suicidal ideation.
Shahani L. Shahani L. J Neuropsychiatry Clin Neurosci. 2013 Winter;25(1):E30. doi: 10.1176/appi.neuropsych.12020033. J Neuropsychiatry Clin Neurosci. 2013. PMID: 23487220 No abstract available.
23 results